Timothy B Petrick insider trades: Entellus Medical (ENTL) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Timothy reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 4, 2017 | ENTL | ↓ Sell | 2,000 | $20.01 | $40K | Direct | Oct 6, 2017 (2d) |
| Sep 22, 2017 | ENTL | ↓ Sell | 2,000 | $18.00 | $36K | Direct | Sep 26, 2017 (4d) |
| Jul 18, 2016 | ENTL | ↓ Sell | 3,000 | $18.15 | $54K | Direct | Jul 19, 2016 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Timothy B Petrick's insider trades
Timothy B Petrick is VP, Research & Development at Entellus Medical (ENTL). Since Jul 18, 2016, Timothy has reported no open-market purchases and 3 sales worth $130K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ENTL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.